Please use this identifier to cite or link to this item:
https://dspace.ctu.edu.vn/jspui/handle/123456789/54670
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nguyễn, Văn Giang | - |
dc.contributor.author | Nguyễn, Gia Anh Tuấn | - |
dc.contributor.author | Nguyễn, Văn Hải | - |
dc.contributor.author | Nguyễn, Đình Luyện | - |
dc.date.accessioned | 2021-06-09T07:49:06Z | - |
dc.date.available | 2021-06-09T07:49:06Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 0866-7861 | - |
dc.identifier.uri | https://dspace.ctu.edu.vn/jspui/handle/123456789/54670 | - |
dc.description.abstract | Pazopanib hydrochloride, a tyrosine kinase inhibitor, was synthesized by combinating indazole 2 and 2,4-dichloropyrimidine and sulfonamide 3 inthe overall yield of 42.7%. The structure of the synthesized intermediates and final product were confirmed by IR, NMR and MS. | vi_VN |
dc.language.iso | vi | vi_VN |
dc.relation.ispartofseries | Tạp chí Dược học;Số 510 .- Tr.56-58 | - |
dc.subject | Indazole | vi_VN |
dc.subject | Sulfonamide | vi_VN |
dc.subject | Pazopanib hydrochloride | vi_VN |
dc.subject | Tyrosine kinase | vi_VN |
dc.title | Nghiên cứu tổng hợp thuốc chống ung thư pazopanib hydroclorid. Phần II: Tổng hợp pazopanib hydroclorid từ 2,3-dimethyl-1H-indazol-6-amin ở quy mô phòng thí nghiệm | vi_VN |
dc.type | Article | vi_VN |
Appears in Collections: | Dược học |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
_file_ Restricted Access | 2.44 MB | Adobe PDF | ||
Your IP: 3.145.50.124 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.